• Agilent and A*STAR's BTI Collaborate on New Bioanalytical Methodologies

News & Views

Agilent and A*STAR's BTI Collaborate on New Bioanalytical Methodologies

Sep 09 2015

Agilent Technologies and the Bioprocessing Technology Institute (BTI), a research institute of Singapore’s Agency for Science, Technology and Research (A*STAR) announced that they will collaborate on new analytical approaches to analysing specific protein-linked sugar compounds. The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterising glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyse minor glycan species.

According to Nino Totino, General Manager for Agilent’s Life Sciences and Applied Markets Group in the South Asia, Pacific and Korea region, there is a critical need in the biopharmaceutical industry for a novel technology platform that can support detailed glycan analysis quickly and effectively in a high throughput environment. Both Agilent and BTI will work together on several projects that could lead to the creation of rigorous, standardised tests for drug safety and efficacy.


Digital Edition

Lab Asia 29.6 Dec

November 2022

In This Edition Chromatography Optimising Viral Vector Purification Strategies with Multimodal Chromatography Key UHPLC Characteristics Required for High throughput LC-MS New Low Volum...

View all digital editions

Events

CPhI & P-MEC China 2022 - NEW DATES

Dec 20 2022 Shanghai, China & Online 21 November 2022 to 13 January 2023

Smart Factory Expo 2023

Jan 25 2023 Tokyo, Japan

Arab Health

Jan 30 2023 Dubai, UAE

Nano Tech 2023

Feb 01 2023 Tokyo, Japan

Medlab Middle East

Feb 06 2023 Dubai, UAE

View all events